PRAMEF25, a member of the PRAME (Preferentially Expressed Antigen in Melanoma) family of genes, is a fascinating subject of study within the field of gene expression. This gene is known to play a role in various biological processes, and understanding the mechanisms that govern its expression is crucial for unraveling the intricate network of gene regulation within the cell. The expression of PRAMEF25 is not constant and can be subject to change in response to various internal and external stimuli. Researchers have identified several chemical agents that can potentially serve as activators, inducing the expression of PRAMEF25. These activators may work through diverse mechanisms, such as changes in the chromatin structure, modulation of transcription factor activity, or alterations in signaling pathways, all of which can lead to an increase in the production of the PRAMEF25 protein.
The potential activators of PRAMEF25 expression span a broad range of chemical entities. Retinoic acid, for example, is known to induce gene expression by interacting with retinoic acid receptors, which in turn can bind to DNA and alter the transcription of genes involved in cellular differentiation and proliferation. Histone deacetylase inhibitors, such as Trichostatin A and Sodium butyrate, also represent a class of compounds that could potentially elevate PRAMEF25 levels by remodeling the chromatin landscape, making it more conducive for transcription. Other compounds like Forskolin and Dexamethasone might stimulate PRAMEF25 expression through the activation of secondary messenger pathways or nuclear hormone receptors, respectively. Additionally, natural compounds such as Sulforaphane and Curcumin are also considered potential inducers, believed to activate detoxification and antioxidant response pathways, which can have a cascading effect on the expression of a multitude of genes, including PRAMEF25. Understanding the interaction between these chemicals and the cellular machinery that controls gene expression is key to deciphering the complex regulatory code of PRAMEF25 and provides a rich area for research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate PRAMEF25 through activation of retinoic acid receptors, leading to transcriptional changes in genes related to cellular differentiation and proliferation pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could stimulate PRAMEF25 expression by engaging with glucocorticoid receptors, which might initiate transcriptional activation of genes involved in immune responses. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could reactivate silenced genes, potentially including PRAMEF25, through demethylation of its promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may upregulate PRAMEF25 by inhibiting histone deacetylases, thus altering chromatin structure to favor transcription of genes governing cell cycle regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could induce PRAMEF25 expression by elevating cAMP levels, activating protein kinase A, and prompting transcriptional changes within cell growth and division signaling pathways. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-estradiol has the potential to stimulate PRAMEF25 expression by binding to estrogen receptors, which could change transcriptional activity in genes linked to reproductive organ development. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may upregulate PRAMEF25 by serving as a histone deacetylase inhibitor, leading to a more transcriptionally active chromatin state, facilitating gene expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin could induce PRAMEF25 expression in response to DNA damage, possibly by triggering a p53-dependent cellular stress response that includes transcriptional activation of certain genes. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
This compound may increase PRAMEF25 expression by activating the Nrf2 signaling pathway, stimulating transcription of genes involved in antioxidant responses and cellular defense mechanisms. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might stimulate PRAMEF25 expression through its inhibition of the NF-κB pathway, which may lead to changes in transcriptional activity of genes involved in cell survival. | ||||||